NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/06/2026
Back to search
Official data from USPTO
TAIWAN BIO THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
01/06/2026
Trademark type
Combined
Nice classes
5, 10, 42
Filing date
01/24/2025
Registration date
01/06/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/06/2026
Last transaction
01/06/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
03
Owner location
Zhubei City, Hsinchu County, TW
Examiner
BLACK, MILDRED ELIZABETH
Law office
N30
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized wording "TAIWAN BIO THERAPEUTICS" to the right of a geometric design composed of three connected components, the top being an incomplete shaded circle, the middle component resembling an oval shape with two pointed edges, and the bottom component being another incomplete shaded circle, that becomes a complete circle when viewed in connection with the middle piece. There is an additional circle inside the bottom component.
Holders and representatives
Holders
TAIWAN BIO THERAPEUTICS INC.
Representatives
Patrick Jay Hines MUNCY, GEISSLER, OLDS & LOWE, P.C.
Technical classification
Nice Classes
Class 5Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Syringes sold filled with pharmaceuticals for the treatment of osteoarthritis and other degenerative joint diseases; Syringes sold filled with pharmaceuticals for chronic wound healingincluding non-healing ulcers; Syringes sold filled with immune-modulating pharmaceuticals for autoimmune diseases and transplant rejection prevention; Syringes sold filled with pharmaceuticals for cardiovascular diseasesincluding acute myocardial infarction and ischemic conditions; Syringes sold filled with regenerative pharmaceuticals for skin and tissue repair; Biological tissue cultures for medical purposes; Medicinal syrups for the treatment of organ transplant rejection; Medicinal syrups for the treatment of transplant-related complications; Pharmaceutical preparationsa blood clotting aid and delivery system for use in human and veterinary medicine; Biological preparations for use in cell cultures for medical purposes; Organotherapy preparations; Stem cells for medical purposes
Class 10
Apparatus for the regeneration of stem cells for medical purposes
Class 42
Providing reagent sample testing and diagnostic services for others for scientific research purposes; Providing medical and scientific research information in the field of clinical trials; Medical research laboratory services; Medical research services; Scientific research in the field of genetics; Research and development of new products for others; Technical writing; Scientific and technological servicesscientific research in the field of stem cell therapy and regenerative medicineincluding treatments for degenerative diseases; Scientific and technological servicesscientific research in the field of cell-based pharmaceuticals and gene-editing technologies for chronic and acute diseases; Scientific and technological servicesscientific research in the field of anti-rejection therapies and regulatory T-cell technologies for organ transplantation; Technological research in the field of cell-based pharmaceutical development and manufacturing technologies; Technological research in the field of immunotherapy and gene therapy; Technological research in the field of treatments for degenerative and cardiovascular diseases; Technological research in the field of medical technology development and clinical applications; Scientific and technological servicesscientific research in the field of manufacturing of medical products
Publications
History of USPTO decisions and trademark events.
19 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/06/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/18/2025
PUBO
PUBLISHED FOR OPPOSITION
11/18/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/12/2025
ALIE
ASSIGNED TO LIE
10/28/2025
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
10/21/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/20/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/14/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/09/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/09/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/10/2025
GNRT
NON-FINAL ACTION E-MAILED
07/10/2025
CNRT
NON-FINAL ACTION WRITTEN
07/10/2025
DOCK
ASSIGNED TO EXAMINER
07/07/2025
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/27/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/27/2025
MAFR
APPLICATION FILING RECEIPT MAILED
01/24/2025
NWAP
NEW APPLICATION ENTERED
01/24/2025
Continuous trademark protection
Get notified about every new filing that threatens TAIWAN BIO THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.